TriCare Prenatal Supplements

Our assessment

Based on FDA adverse event data, the overall safety profile for this supplement shows a low rate of serious adverse events relative to its widespread use. The data indicates that most reported reactions are manageable and not life-threatening, though vigilance is required for specific symptoms. The most important finding is that serious outcomes remain rare, but they are documented and must be communicated clearly to ensure patient safety FDA FAERS ↗.

Safety profile

FDA received a total of 39 adverse event reports for this supplement. The most frequently reported side effects include nausea (9 reports), diarrhea (6 reports), and abdominal pain (5 reports). Less common but notable side effects include headache (4 reports), dizziness (3 reports), and fatigue (3 reports). Serious side effects, though uncommon, include one report of anaphylactic reaction and one report of angioedema FDA FAERS ↗.

How it works

Data not available on mechanism of action from the provided sources. No specific drug interactions are listed in the provided data FDA FAERS ↗.

Our recommendation

Patients should monitor for the most common side effects — nausea, diarrhea, and abdominal pain — especially when first starting the supplement. If these symptoms persist, discontinue use and consult a healthcare provider. Given the reports of anaphylactic reaction and angioedema, individuals with a history of severe allergies should exercise caution and seek immediate medical attention if they experience difficulty breathing, swelling of the face or throat, or hives FDA FAERS ↗.